Femigrace Tablet is an oral hormonal combination, containing Ethinylestradiol and Cyproterone used to treat symptoms of polycystic ovary syndrome (PCOS) such as acne, excessive hair growth (hirsutism), and irregular periods. Polycystic ovary syndrome is a common condition, which affects how women's ovaries work. 

Femigrace Tablet is a combination of two hormonal medications, ethinylestradiol, and cyproterone used to treat PCOS symptoms such as acne, excessive hair growth (hirsutism), and irregular periods. Cyproterone, works by blocking a male hormone named androgen overproduction in the ovaries and reducing unwanted facial hair growth and acne. Ethinylestradiol, on the other hand, acts as an enhancer. It enhances the effect of cyproterone by reducing the amount of androgens in the blood. Collectively, they both effectively treat the symptoms of PCOS.

Femigrace Tablet can be taken with or without food in dose and duration as prescribed by your doctor. For best results of Femigrace Tablet , take it at the same time every day. Also, do not stop taking Femigrace Tablet before completing its full course, even if you feel your symptoms are better. The most common side effects of Femigrace Tablet  include weight gain, nausea, tender breast, stomach pain, and headache. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. If you see swelling or pain in your limbs, chest pain, or shortness of breath, please inform your doctor.

Inform your doctor if your periods do not start within a week after taking Femigrace Tablet . Do not take Femigrace Tablet if you are pregnant already or breastfeeding. Femigrace Tablet does not prevent the transmission of any sexually transmitted disease (STD), so use some other form of contraception (condom) during sexual intercourse if you have any STD or AIDS (acquired immunodeficiency syndrome). If you have any blood clots, please consult your doctor as Femigrace Tablet may not be prescribed.

Femigrace Tablet is a combination of two hormonal drugs, ethinylestradiol, and cyproterone. It is used to treat PCOS symptoms such as acne, excessive hair growth (hirsutism), and irregular periods. Cyproterone works by blocking a male hormone named androgen overproduction in the ovaries and reducing unwanted facial hair growth and acne. Ethinylestradiol, on the other hand, acts as an enhancer. It enhances the effect of cyproterone by reducing the amount of androgens in the blood. Collectively, they both effectively treat the symptoms of PCOS.

If you are allergic to Femigrace Tablet , please inform your doctor. Please undergo regular cervical smear test while taking Femigrace Tablet . Also, check your breast every month for changes such as if you feel lumps, see anything odd, please inform your doctor. If you need to undergo any surgery, please inform your doctor as Femigrace Tablet needs to be stopped 4-6 weeks before the surgery to avoid any risk of blood clots. If you smoke, are obese, have a history of blood clots, do not use Femigrace Tablet . Also, do not stop taking Femigrace Tablet before completing its full course, even if you feel your symptoms are better. If you see swelling or pain in your limbs, chest pain, or shortness of breath, please inform your doctor. Inform your doctor if your periods do not start within a week after taking Femigrace Tablet . Also, tell about all the medicines you are taking to your doctor before starting Femigrace Tablet . Do not take Femigrace Tablet if you are pregnant already or breastfeeding. If you have missed a dose or are late by 12 hours, please wear a condom for 2 days while sexual intercourse to avoid unwanted pregnancy.

• Discontinue using any birth control pills, Femigrace Tablet  also acts as a contraceptive.
• Femigrace Tablet may cause a patchy, darkening of the skin on the face (melasma). Sunlight may intensify this darkening, and you may need to avoid prolonged sun exposure and sunlamps.